Cannabinoids
The evidence bar impacting UK medical cannabis access
November 6, 2026Cannabinoids, Chronic Diseases, Legislation, NICE, Pharmacy, chronic pain, drug approval
By Mike Morgan-Giles Private prescribing of cannabis-based medicines in the UK has more than doubled in a year. Getting the …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
